Nonalcoholic fatty liver in a developing country is responsible for significant liver disease

Hepatology

Volumn 52, Issue 6, 2010, Pages 2248-2249

  Duseja, Ajay ^a   Sharma, Balkrishan ^a   Kumar, Amit ^a   Kapil, Shweta ^a   Das, Ashim ^a   Dhiman, Radha K ^a   Chawla, Yogesh K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; ENDOMYSIUM ANTIBODY; FERRITIN; IRON; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; TRANSFERRIN;

AMINOTRANSFERASE BLOOD LEVEL; ASIAN; BIOCHEMISTRY; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRYPTOGENIC CIRRHOSIS; CRYPTOGENIC HEPATOCELLULAR CARCINOM; DEVELOPING COUNTRY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DUODENUM BIOPSY; FERRITIN BLOOD LEVEL; GASTROSCOPY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS; HEPATITIS B; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; IRON BINDING CAPACITY; IRON OVERLOAD; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; METABOLIC DISORDER; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

CARCINOMA, HEPATOCELLULAR; FATTY LIVER; INDIA; LIVER CIRRHOSIS; LIVER NEOPLASMS; OVERWEIGHT; PREVALENCE; RISK FACTORS;

EID: 78649622081     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23838     Document Type: Letter

References (12)

1. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602.
2. Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, et al. Clinicopathological profile of Indian patients with nonalcoholic fatty liver disease is different from the West. Dig Dis Sci 2007; 52: 2368-2374.
3. Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, et al. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol 2007; 13: 649-650.
4. Dhiman RK, Duseja A, Chawla Y. Asians need different criteria for defining overweight and obesity. Arch Intern Med 2005; 165: 1069-1070.
5. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia: Health Communications Australia; 2000: 8-56.
6. Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23: 1136-1142.
7. Misra A, Misra R. Asian Indians and insulin resistance syndrome: global perspective. Metab Syndr Relat Disord 2003; 1: 277-283.
8. Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol 2005; 11: 393-395.
9. Duseja A, Das R, Das A, Dhiman RK, Chawla Y, Garewal G. Serum iron and hepatic iron overload in patients with nonalcoholic steatohepatitis. Dig Dis Sci 2006; 51: 1730-1731.
10. Duseja A, Nanda M, Das A, Das R, Bhansali A, Chawla Y. Prevalence of obesity, diabetes mellitus and hyperlipidemia in patients with cryptogenic liver cirrhosis. Trop Gastroenterol 2004; 25: 15-17.
11. Bruix J, Sherman M, for the Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. HEPATOLOGY 2005; 42: 1208-1236.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.